Featured Research

from universities, journals, and other organizations

Long jumpers do better with a spring in their step

Date:
July 2, 2014
Source:
Society for Experimental Biology
Summary:
Long jumpers and triple jumpers spend hours training to perfect their take-off. But what influences their performance? Scientists have discovered that taking off from a compliant surface -- such as a springboard -- compared with a firm, unyielding surface, reduces the energy cost of jumping over long distances.

Athletes test the effectiveness of different take-off surfaces.
Credit: Dr. Lewis Halsey

Long jumpers and triple jumpers spend hours training to perfect their take-off. But what influences their performance? Scientists have discovered that taking off from a compliant surface (such as a springboard) compared with a firm, unyielding surface, reduces the energy cost of jumping over long distances.

Dr Lewis Halsey and his colleagues conducted the study on trained athletes, capable of undertaking jumps repeatedly. The participants jumped a set distance (1.2 or 1.8 m), taking off from a range of different surfaces. Each wore a portable gas analyser to measure oxygen consumption, a good indication of energy expenditure. As predicted, the highest energy costs were caused by taking off from soft surfaces, such as thick crash mats. For the longer distance, however, jumping from a springboard was less energetically expensive than using a firm surface.

There are two possible explanations for this. Firstly, a compliant surface allows the angle of take-off to be closer to the optimum of 45 degrees, which gives maximum energy efficiency. Alternatively, firm surfaces cause the calf muscle to be used more, which produces energy less efficiently than the thigh muscle because it has to contract more quickly. Surprisingly, for the shorter distance, no difference was observed in the energy expenditure for firm and springy surfaces. Dr Halsey believes this may be due to the jumps being "too easy" for the athletes such that the take-off angle or muscle group used had little effect.

This research was presented at the Society for Experimental Biology Annual Meeting 2014 held at Manchester University, UK, from the 1st - 4th of July.


Story Source:

The above story is based on materials provided by Society for Experimental Biology. Note: Materials may be edited for content and length.


Cite This Page:

Society for Experimental Biology. "Long jumpers do better with a spring in their step." ScienceDaily. ScienceDaily, 2 July 2014. <www.sciencedaily.com/releases/2014/07/140702203812.htm>.
Society for Experimental Biology. (2014, July 2). Long jumpers do better with a spring in their step. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/07/140702203812.htm
Society for Experimental Biology. "Long jumpers do better with a spring in their step." ScienceDaily. www.sciencedaily.com/releases/2014/07/140702203812.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins